Page last updated: 2024-08-23

sq-11725 and Hemorrhage

sq-11725 has been researched along with Hemorrhage in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (40.00)	18.2507
2000's	3 (60.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abecasis, R; Ameigeiras, B; Argonz, J; Dominguez, N; Fassio, E; Garcia, D; Isla, R; Kravetz, D; Landeira, G; Romero, G; Terg, R	1
Bernardi, M; Berzigotti, A; Bracci, E; Caraceni, P; Di Micoli, A; Domenicali, M; Felline, P; Savelli, F; Trevisani, F; Zambruni, A; Zoli, M	1
Campanati, L; Di Mauro, P; Gridelli, B; Langer, M; Peta, M; Pezzi, A; Pifferi, S; Prato, P; Proietti, D; Quarenghi, E	1
García-Tsao, G	1
Bellini, B; Bighin, R; Bolognesi, M; Bombonato, G; Gatta, A; Merkel, C; Sacerdoti, D	1

Trials

3 trial(s) available for sq-11725 and Hemorrhage

Article	Year
Nadolol plus spironolactone in the prophylaxis of first variceal bleed in nonascitic cirrhotic patients: A preliminary study. Hepatology (Baltimore, Md.), 2003, Volume: 37, Issue:2 Topics: Adrenergic beta-Antagonists; Aged; Double-Blind Method; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Hemodynamics; Hemorrhage; Humans; Liver Cirrhosis; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Nadolol; Spironolactone; Splanchnic Circulation; Treatment Outcome	2003
Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis. Journal of hepatology, 2008, Volume: 48, Issue:3 Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Blood Pressure; Electrocardiography; Esophageal and Gastric Varices; Female; Heart Rate; Hemorrhage; Hepatic Veins; Humans; Liver Cirrhosis; Male; Middle Aged; Models, Biological; Nadolol; Prognosis; Risk Factors; Ventricular Function	2008
Beta-adrenergic antagonists to prevent bleeding from esophageal varices: a risk during liver transplantation? Transplantation proceedings, 1994, Volume: 26, Issue:6 Topics: Adult; Cardiac Output; Esophageal and Gastric Varices; Female; Heart Rate; Hemorrhage; Humans; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Liver Transplantation; Male; Middle Aged; Monitoring, Intraoperative; Nadolol; Oxygen; Propranolol; Risk Factors	1994

Other Studies

2 other study(ies) available for sq-11725 and Hemorrhage

Article	Year
Further evidence in favor of pharmacological portal pressure reduction in the prevention of variceal hemorrhage. Gastroenterology, 1997, Volume: 112, Issue:5 Topics: Antihypertensive Agents; Drug Therapy, Combination; Hemorrhage; Humans; Isosorbide Dinitrate; Nadolol; Prospective Studies; Randomized Controlled Trials as Topic; Sclerotherapy; Varicose Veins; Vasodilator Agents	1997
The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology (Baltimore, Md.), 2000, Volume: 32, Issue:5 Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Hemodynamics; Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Nadolol; Prognosis; Vasodilator Agents	2000

Article

Year

Further evidence in favor of pharmacological portal pressure reduction in the prevention of variceal hemorrhage.

Gastroenterology, 1997, Volume: 112, Issue:5

Topics: Antihypertensive Agents; Drug Therapy, Combination; Hemorrhage; Humans; Isosorbide Dinitrate; Nadolol; Prospective Studies; Randomized Controlled Trials as Topic; Sclerotherapy; Varicose Veins; Vasodilator Agents

1997

The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis.

Hepatology (Baltimore, Md.), 2000, Volume: 32, Issue:5

Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Drug Therapy, Combination; Esophageal and Gastric Varices; Female; Hemodynamics; Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Male; Middle Aged; Nadolol; Prognosis; Vasodilator Agents

2000